Klaus Stockemann

  • Managing Partner, Peppermint Venture Partners, Berlin, Germany

    Klaus is Managing Partner & Co-Founder of Peppermint VenturePartners which recently launched the Charité Biomedical Fund. Before this he was a General Partner in 3i`s international Healthcare Venture Team. He has more than 12 years Pharma experience with leading roles at Schering AG and ASTA Medica a Degussa&Hüls group company in R&D and Business Development. He holds a Ph.D in Biology and Pharmacology from the University of Mainz as well as a MBA from WHU / Kellogg Northwestern University in the US. Klaus has more than 12 year of experience in the Venture Capital Industry and was on 3i’s side responsible for many investments and IPO’s including Epigenomics. Jerini, Santhera as well as the trade sales of Evotec Neuroscience, Amaxa and Elbion. Klaus has been board member of Combinature, Epigenomics, Jerini, Elbion, Evotec Neuroscience, Amaxa, Immatics as well as IntelliDx and Zonare in the US. He focuses on Medical Devices and special Pharma investments. He currently is chairman of the boards of Humedics and Hematris Wound Care.

  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!